We are live on
!
Find out more
ECM
Exchange Capital Management Portfolio holdings
AUM
$670M
1-Year Est. Return
14.6%
This Fund
S&P 500
This Quarter
Est. Return
+2.02%
1 Year Est. Return
+14.6%
3 Year Est. Return
+57.79%
5 Year Est. Return
+93.67%
10 Year Est. Return
+232.74%
AUM
$380M
AUM Growth
+$7.73M
(+2.1%)
Cap. Flow
+$1.71M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
153
New
18
Increased
60
Reduced
66
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.69M |
| 2 |
Biogen
BIIB
|
+$1.86M |
| 3 |
Blackrock
BLK
|
+$1.31M |
| 4 |
Microchip Technology
MCHP
|
+$1.14M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.94M |
| 2 |
Diamondback Energy
FANG
|
+$2.22M |
| 3 |
Apple
AAPL
|
+$2.11M |
| 4 |
McKesson
MCK
|
+$1.23M |
| 5 |
Fortinet
FTNT
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.65% |
| 2 | Healthcare | 9.69% |
| 3 | Financials | 8.72% |
| 4 | Consumer Discretionary | 5.82% |
| 5 | Communication Services | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Citigroup
C
$213B
| – | – |
-12,230
| Closed | -$856K |
|
|
152
Diamondback Energy
FANG
$56B
| – | – |
-20,342
| Closed | -$2.22M |
|
|
AGN
153
DELISTED
Allergan plc
AGN
| – | – |
-17,536
| Closed | -$2.94M |
|
Similar funds
BC
CCP
TSWM
BWA
WCWM
SXL
SC
FGC
Exchange Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Exchange Capital Management held 153 positions worth $380M, up 2.1% from $372M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Exchange Capital Management's Q3 2019 filing shows 18 new, 60 increased, 66 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 57,215 shares worth $2.9M. The largest sale was Allergan plc, an estimated $2.94M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
- Exchange Capital Management's largest Q3 2019 buy was Bristol-Myers Squibb: 57,215 shares worth $2.9M.
- Exchange Capital Management added most to Blackrock in Q3 2019, an estimated $1.31M increase.
- Exchange Capital Management's biggest Q3 2019 reduction was Apple, cutting an estimated $2.11M.
- Exchange Capital Management fully exited Allergan plc in Q3 2019, selling an estimated $2.94M.
- Exchange Capital Management's ten largest holdings make up 24% of its $380M portfolio in Q3 2019.
- Exchange Capital Management opened 18 new positions and closed 3 in Q3 2019.
- Exchange Capital Management's portfolio value rose 2.1% quarter-over-quarter to $380M.
Based on Exchange Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.